Skip to content

Effect of Clonazepam and Tranquival on Muscular Pain, Sleep Disorders, and Anxiety in Addicted Patients

Effect of Clonazepam and Tranquival on Muscular Pain, Sleep Disorders, and Anxiety in Addicted Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201306222085N10
Enrollment
69
Registered
2013-11-17
Start date
2012-10-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid addiction. Mental and behavioural disorders due to use of opioids

Interventions

Intervention 1: Tranquival group: In Tranquival group, the patients took one pill of Tranquival (Dineh Co -Iran) orally an hour before sleep every night for 6 weeks. The ingredients of Tranquival pill
Treatment - Drugs
Tranquival group: In Tranquival group, the patients took one pill of Tranquival (Dineh Co -Iran) orally an hour before sleep every night for 6 weeks. The ingredients of Tranquival pill are 150 mg Vale
Clonazepam group: In Clonazepam group, the patients took 1mg Clonazepam pill (Arya Co- Iran) orally an hour before sleep every night for 6 weeks.

Sponsors

Vice chancellor for research and technology, Shahrekord University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria were age 20 to 50 years old, history of heroin use for at least two years (0.5 to 1 gr/day), suffering from withdrawal syndrome, being treated with Methadone 30 to 60 mg/day, lack of allergy to Passiflora, Valeriana officinalis, Humulus lupulus , and Melissa officinalis, and previous referral to an addiction treatment clinic. Exclusion criteria were having psychological disorders or history of hospitalization in a psychiatric ward, unwillingness to continue participation in the study, and occurrence of any side effects related to Tranquival.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Anxiety. Timepoint: At the beginning of the study, 2 weeks later, and at the end of study. Method of measurement: Hamilton Anxiety Rating Scale.;Quality of sleep. Timepoint: At the beginning of the study, 2 weeks later, and at the end of study. Method of measurement: Pittsburgh Sleep Quality Index.;Muscular pain. Timepoint: At the beginning of the study, 2 weeks later, and at the end of study. Method of measurement: Visual Analogue Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNeda Parvin

Shahrekord University of Medical Sciences

np285@yahoo.com+98 38 1333 5652

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026